DocMorris AG Issues CHF 100 Million Convertible Bonds

DocMorris AG announced the private placement of approximately CHF 100 million in convertible bonds due 2031. The initiative aims to facilitate the early repurchase of existing convertible bonds set to mature in 2028. This strategic move is intended to proactively manage dilution and reduce potential shareholder impact by decreasing the number of shares from 7.6 million to 7.0 million. Additionally, the bonds come with a reduced coupon rate between 1.5% and 2.0%, contrasted with the current 3.0% rate.

The issuance extends the maturity profile by 2.6 years, from 2028 to 2031. DocMorris plans to leverage favorable share price performance to optimize its balance sheet and funding costs, supporting sustainable growth. The New Bonds will feature a premium conversion price, expected to be 27.5% to 32.5% above the trading reference price.

The company is conducting this transaction on a private placement basis for professional investors primarily in Switzerland, with additional offerings under RegS Category 1 internationally.